Free Trial

LifeMD (LFMD) Competitors

LifeMD logo
$6.33 +0.04 (+0.64%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$6.39 +0.06 (+0.93%)
As of 08/22/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LFMD vs. OMDA, GRAL, PNTG, FTRE, FLGT, CDNA, CSTL, AUNA, INNV, and SBC

Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Omada Health (OMDA), GRAIL (GRAL), The Pennant Group (PNTG), Fortrea (FTRE), Fulgent Genetics (FLGT), CareDx (CDNA), Castle Biosciences (CSTL), Auna (AUNA), InnovAge (INNV), and SBC Medical Group (SBC). These companies are all part of the "healthcare" industry.

LifeMD vs. Its Competitors

Omada Health (NASDAQ:OMDA) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

Omada Health has higher earnings, but lower revenue than LifeMD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omada Health$209.83M5.85N/AN/AN/A
LifeMD$212.45M1.41-$18.88M-$0.21-30.14

Omada Health presently has a consensus price target of $24.57, suggesting a potential upside of 15.25%. LifeMD has a consensus price target of $13.17, suggesting a potential upside of 108.00%. Given LifeMD's higher probable upside, analysts clearly believe LifeMD is more favorable than Omada Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omada Health
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00
LifeMD
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.00

Omada Health has a net margin of 0.00% compared to LifeMD's net margin of -2.41%.

Company Net Margins Return on Equity Return on Assets
Omada HealthN/A N/A N/A
LifeMD -2.41%N/A -8.11%

35.5% of LifeMD shares are held by institutional investors. 18.4% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, LifeMD had 6 more articles in the media than Omada Health. MarketBeat recorded 8 mentions for LifeMD and 2 mentions for Omada Health. Omada Health's average media sentiment score of 0.67 beat LifeMD's score of 0.09 indicating that Omada Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Omada Health
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LifeMD
0 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

LifeMD beats Omada Health on 6 of the 11 factors compared between the two stocks.

Get LifeMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFMD vs. The Competition

MetricLifeMDMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$300.15M$7.82B$5.81B$9.76B
Dividend YieldN/A2.69%4.39%4.06%
P/E Ratio-30.1478.4731.3626.05
Price / Sales1.4150.60387.8788.42
Price / CashN/A25.3638.0259.36
Price / Book633.0024.799.536.60
Net Income-$18.88M$243.33M$3.26B$265.65M
7 Day Performance-1.56%1.08%2.14%2.00%
1 Month Performance-40.67%0.70%3.22%0.46%
1 Year Performance16.15%10.42%30.18%18.88%

LifeMD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFMD
LifeMD
2.6059 of 5 stars
$6.33
+0.6%
$13.17
+108.0%
+16.1%$300.15M$212.45M-30.14230News Coverage
OMDA
Omada Health
N/A$20.91
+1.9%
$24.57
+17.5%
N/A$1.18BN/A0.00849News Coverage
Positive News
GRAL
GRAIL
1.1472 of 5 stars
$32.80
+1.1%
$31.50
-4.0%
+122.2%$1.17B$125.60M-2.501,360Insider Trade
PNTG
The Pennant Group
3.6866 of 5 stars
$25.11
-0.6%
$33.40
+33.0%
-28.0%$873.04M$695.24M32.197,000
FTRE
Fortrea
3.853 of 5 stars
$7.92
-1.5%
$13.30
+67.9%
-62.1%$730.03M$2.70B-0.7015,500
FLGT
Fulgent Genetics
3.6776 of 5 stars
$21.52
+1.2%
$25.33
+17.7%
-8.5%$650.75M$283.47M-12.961,313Positive News
CDNA
CareDx
4.3056 of 5 stars
$11.85
+0.1%
$27.67
+133.5%
-58.9%$630.21M$333.79M11.62740
CSTL
Castle Biosciences
2.5485 of 5 stars
$20.56
+2.3%
$37.00
+80.0%
-29.5%$582.78M$332.07M-58.74540
AUNA
Auna
4.3681 of 5 stars
$6.27
-0.7%
$10.70
+70.8%
-20.3%$467.02M$1.17B10.8014,842News Coverage
Earnings Report
Analyst Upgrade
INNV
InnovAge
2.1634 of 5 stars
$3.53
+2.9%
$5.00
+41.6%
-40.9%$463.09M$763.85M-15.352,350
SBC
SBC Medical Group
N/A$4.24
-4.9%
N/AN/A$462.11M$205.42M13.25N/ANews Coverage
Analyst Revision

Related Companies and Tools


This page (NASDAQ:LFMD) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners